amino}-4-methoxy-5-{[4-(1-methyl-1h-indol-3-yl)pyrimidin](https://cpimg.tistatic.com/06463250/b/4/Osimertinib-Mesylate-AZD9291-CAS-1421373-65-0.gif)
Osimertinib Mesylate Azd9291 Cas 1421373-65-0 Chemical Name: N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1h-indol-3-yl)pyrimidin
Price Trend: 1.00 - 5.00 USD / Gram
Get Latest Price
Minimum Order Quantity :
1 Gram
Brand Name :
Dm
In Stock
Product Specifications
| Color | white powder |
| Structural Formula | C28H33N7O2 |
| Molecular Formula | C28H33N7O2 |
| Storage | Room Temperature |
| Smell | No Smell |
| Taste | Odorless |
| Molecular Weight | 499.61 Grams (g) |
| Shelf Life | 2 Years |
| Medicine Name | AZD929/Osimertinib |
| Chemical Name | N-(2-{[2-(Dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin |
| CAS No | 1421373-65-0 |
| Type | Pharmaceutical Intermediates |
| Grade | Medicine Grade |
| Usage | human pharma |
| Purity(%) | 99 |
| Appearance | white powder |
| Physical Form | Powder |
| FOB Port | shanghai |
| Payment Terms | Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Days after Acceptance (DA) |
| Supply Ability | 150 Per Month |
| Delivery Time | 7 Days |
| Sample Policy | If order is confirmed we will reimburse the sample cost |
| Packaging Details | double PE+aluminium bag |
| Main Export Market(s) | Asia, Australia, Central America, South America, Western Europe, North America |
| Main Domestic Market | All India |
| Certifications | ISO9001 |
Product Overview
Key Features
CAS NO: 1421373-65-0
Name:AZD-9291,AZD9291
Synonyms:N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide
Molecular formula : C28H33N7O2.CH4O3S
Molecular weight:595.71
Product name:
Osimertinib (previously known as mereletinib or AZD9291) is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor drug.
AZD9291 is a Kinase Inhibitor. The mechanism of action of osimertinib is as a Kinase Inhibitor, and Cytochrome P450 3A Inhibitor, and Cytochrome P450 3A4 Inducer, and Cytochrome P450 1A2 Inducer, and Breast Cancer Resistance Protein Inhibitor.
As this agent is selective towards mutant forms of EGFR, its toxicity profile may be reduced when compared to non-selective EGFR inhibitors which also inhibit wild-type EGFR.
Company Details
Business Type
Exporter, Manufacturer, Supplier
Employee Count
25
Establishment
2014
Working Days
Monday To Sunday
Related Products
Explore Related Categories
More Product From This seller
Seller Details
Shijiazhuang, Hebei
General Manager
Ms. Lily
Address
B No.52 Zhaiying South street,Yuhua Dostrict, Shijiazhuang, Hebei, 050000, China
api intermediate in Shijiazhuang
Report incorrect details

































